文献速递鼻科

德国慢性鼻窦炎患者用药的大规模回顾性研究

Medication use in patients with chronic rhinosinusitis in Germany - a large retrospective patient-based study.
PubMed 文献 · Rhinology · 2019-01-01

该研究基于德国940家全科和106家耳鼻咽喉科诊所的数据,分析2015年诊断为慢性鼻窦炎(ICD-10: J32)或鼻息肉(ICD-10: J33)患者的用药情况。结果显示,慢性鼻窦炎患者局部糖皮质激素处方率在全科为12.3%、耳鼻咽喉科为34.3%,鼻息肉患者则分别为27.3%和71.2%。结论认为德国全科诊所局部糖皮质激素使用率与其他西方国家一样低,应鼓励在伴鼻息肉患者中增加使用。

要点

  • 慢性鼻窦炎患者局部糖皮质激素使用率全科12.3%、耳鼻咽喉科34.3%。
  • 鼻息肉患者局部糖皮质激素使用率全科27.3%、耳鼻咽喉科71.2%。
  • 应鼓励在全科和耳鼻咽喉科增加伴鼻息肉患者的局部激素使用。

核心结论

  • 德国全科诊所慢性鼻窦炎患者局部糖皮质激素使用率与其他西方国家一样低。
  • 应鼓励在全科和耳鼻咽喉科增加伴鼻息肉患者的局部糖皮质激素使用。

研究设计与样本

  • 回顾性研究,使用IQVIA Disease Analyzer数据库。
  • 纳入940家全科和106家耳鼻咽喉科诊所2015年诊断为慢性鼻窦炎(J32)或鼻息肉(J33)的患者。
  • 全科诊所:慢性鼻窦炎26,768例,鼻息肉516例;耳鼻咽喉科诊所:慢性鼻窦炎19,826例,鼻息肉1,773例。

主要发现

  • 慢性鼻窦炎(J32)患者局部糖皮质激素处方率:全科12.3%,耳鼻咽喉科34.3%。
  • 鼻息肉(J33)患者局部糖皮质激素处方率:全科27.3%,耳鼻咽喉科71.2%。

临床怎么用

  • 德国全科诊所慢性鼻窦炎患者局部糖皮质激素使用率较低。
  • 在伴鼻息肉患者中,应鼓励全科和耳鼻咽喉科增加局部糖皮质激素使用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The aim of the present study was to provide an insight into medical treatment practices among patients with chronic rhinosinusitis (CRS) in Germany. An investigation of ICD codes and ATC classes of CRS patients in general and otolaryngology offices in Germany should reveal the prevalent treatment behaviors of German physicians. METHODS: The present study used data from the Disease Analyzer database (IQVIA). The study sample included patients from 940 general (GP) and 106 otolaryngology (ENT) practices who were coded as having chronic sinusitis (ICD-10: J32) or nasal polyps (ICD-10: J33) in 2015 (index date). The primary outcome measures were the number of patients with these diagnoses per practice as well as the proportion of patients with prescriptions for topical corticosteroids, systemic corticosteroids, antibiotics, antihistamines, and local decongestants within 365 days after the first diagnosis. RESULTS: This retrospective study included 26,768 patients with coding for chronic sinusitis (ICD-10: J32) and 516 patients for nasal polyps (ICD-10: J33) in 940 GP practices and 19,826 patients with coding for chronic sinusitis (ICD-10: J32) and 1,773 patients for nasal polyps (ICD-10: J33) in 106 ENT practices. In patients coded as having chronic sinusitis (ICD-10: J32), topical corticosteroids were prescribed at a low rate (GP: 12.3%, ENT: 34.3%). In patients coded as having nasal polyps (ICD-10: J33), topical corticosteroid usage was higher in GP practices (27.3%) and in ENT practices (71.2%). CONCLUSIONS: Topical corticosteroid usage in CRS patients in GP practices in Germany is as low as in other Western countries. Increased usage of topical corticosteroids in CRS patients with polyposis should be encouraged in GP and ENT practices.

来源:Rhinology,查看原文。版权归原作者所有。

引用

  1. Park JJH, Seidel DU, Bachert C, et al. Medication use in patients with chronic rhinosinusitis in Germany - a large retrospective patient-based study. Rhinology. 2019. PMID: 30076702. doi:10.4193/Rhin18.055

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。